Virtual Library

Start Your Search

Sali Gradica



Author of

  • +

    P3.16 - Treatment of Early Stage/Localized Disease (Not CME Accredited Session) (ID 982)

    • Event: WCLC 2018
    • Type: Poster Viewing in the Exhibit Hall
    • Track:
    • Presentations: 1
    • Moderators:
    • Coordinates: 9/26/2018, 12:00 - 13:30, Exhibit Hall
    • +

      P3.16-23 - Soft-Tissue Sarcoma of the Chest Wall, Surgical Resection: Analysis Our Cases Period of Time Decembre 2004-July 2017 (ID 11123)

      12:00 - 13:30  |  Author(s): Sali Gradica

      • Abstract
      • Slides

      Background

      Soft tissues include muscle, fat, blood vessels, nerves, tendons and joint linings (synovial tissue). Cancerous tumors (sarcomas) of the soft tissue are rare, but there are many types. Because soft tissue sarcomas arise from a number of different kinds of tissue, they can occur anywhere in the body. Outcomes for people with soft tissue sarcomas depend on the type, size, grade, stage and location of the tumor, as well as a person's age and general health. Clasification from grade are :low ,midle ,high diferenciations..Aim of Study: Our objective was to introduce a patient diagnosed with neglectetd giant soft tissue chest wall liposarcoma .

      a9ded1e5ce5d75814730bb4caaf49419 Method

      Records of 32 patients admitted to our institution from January 2004 to July 2017 were treated in our clinic’ A patient with the initials K.B bored 17/06/1950 .He was admitted to our hospital in thoracal surgery at 19.09.2012 with diagnosis : soft tissue tumor left chest wall .Pacienti without other diseases . We did all necessary examinations , CT , MRI and determined the extent of tissue tumor.

      4c3880bb027f159e801041b1021e88e8 Result

      Ages ranged from 13 to 86 years (median, 38 years); the ratio of male to female patients was 3:1. The initial complaint was mass or pain in 98% of the cases. Histologic types were as follows: desmoid tumor (n = 5), 15 %; liposarcoma (n = 7), 21%; rhabdomyosarcoma (n = 6), 18%); fibrosarcoma (n =4 , 12%); malignant peripheral nerve tumor (n = 3, 9%); malignant fibrous histiocytoma (n = 1, 3%); tenosynovial sarcoma (n = 1),3 %; hemangiopericytoma (n = 2) ,6%%); alveolar soft part sarcoma (n = 2),6%); and other types(lymphoma) (n = 2),6%). Resection was the primary treatment in 28 cases (87%).All patients were treated by multimodal treatment ,chemoradition therapy and surgery. Local recurrence developed in 25%. Metastases occurred in 15 (46%) of the cases (metachronous in 12, synchronous in 3) and were more common in patients with high-grade disease than in those with low-grade disease Overall 5-year survival was 60%. Five-year survival rate for those with high-grade sarcomas was significantly lower than that for low-grade sarcomas .Tumor size and age of patient were not prognostic.

      8eea62084ca7e541d918e823422bd82e Conclusion

      Surgery is important in the treatment of most sarcomas.[Additional treatments, including chemotherapy and radiation therapy, may be administered before and/or after surgery. Thoracic wall soft-tissue sarcomas are best controlled by wide surgical resection.

      6f8b794f3246b0c1e1780bb4d4d5dc53

      Only Active Members that have purchased this event or have registered via an access code will be able to view this content. To view this presentation, please login or select "Add to Cart" and proceed to checkout.